Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in...

Journal of Clinical Oncology 2013 / 09 Vol. 31; Iss. 27

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Sequist, L. V., Yang, J. C.-H., Yamamoto, N., O'Byrne, K., Hirsh, V., Mok, T., Geater, S. L., Orlov, S., Tsai, C.-M., Boyer, M., Su, W.-C., Bennouna, J., Kato, T., Gorbunova, V., Lee, K. H., Shah, R.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2012.44.2806
Date:
September, 2013
File:
PDF, 296 KB
english, 2013
Conversion to is in progress
Conversion to is failed